S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. (Q45911403)

17 December 2017

title

S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. (English)

1 reference

17 December 2017

author name string

James N Tsoporis

1

1 reference

17 December 2017

Shehla Izhar

2

1 reference

17 December 2017

Gerald Proteau

3

1 reference

17 December 2017

Graham Slaughter

4

1 reference

17 December 2017

Thomas G Parker

5

1 reference

17 December 2017

publication date

23 August 2011

1 reference

17 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

17 December 2017

volume

52

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

464-473

1 reference

17 December 2017

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

S100B expression modulates left ventricular remodeling after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Intracellular and extracellular roles of S100 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

S100beta inhibits alpha1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Early expression of angiogenesis factors in acute myocardial ischemia and infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

VEGF receptor signalling - in control of vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Role of vascular endothelial growth factor in regulation of physiological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Vascular endothelial growth factor is required for coronary collateral growth in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases, and S6 kinase in cultured rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

A growth factor for cardiac myocytes is produced by cardiac nonmyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

The ischemic rat heart releases S100B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

Biochemical evidence for cellular dedifferentiation in adult rat cardiac muscle cells in culture: expression of myosin isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.015

10.1016/J.YJMCC.2011.08.015

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

21889514

1 reference

17 December 2017